Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.
Publication
, Journal Article
Vaduganathan, M; Greene, SJ
Published in: JAMA
June 25, 2014
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
June 25, 2014
Volume
311
Issue
24
Start / End Page
2541 / 2542
Location
United States
Related Subject Headings
- Warfarin
- Renal Insufficiency, Chronic
- Myocardial Infarction
- Male
- Humans
- General & Internal Medicine
- Female
- Atrial Fibrillation
- Anticoagulants
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vaduganathan, M., & Greene, S. J. (2014). Influence of chronic kidney disease on warfarin therapy for atrial fibrillation. JAMA, 311(24), 2541–2542. https://doi.org/10.1001/jama.2014.5576
Vaduganathan, Muthiah, and Stephen J. Greene. “Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.” JAMA 311, no. 24 (June 25, 2014): 2541–42. https://doi.org/10.1001/jama.2014.5576.
Vaduganathan M, Greene SJ. Influence of chronic kidney disease on warfarin therapy for atrial fibrillation. JAMA. 2014 Jun 25;311(24):2541–2.
Vaduganathan, Muthiah, and Stephen J. Greene. “Influence of chronic kidney disease on warfarin therapy for atrial fibrillation.” JAMA, vol. 311, no. 24, June 2014, pp. 2541–42. Pubmed, doi:10.1001/jama.2014.5576.
Vaduganathan M, Greene SJ. Influence of chronic kidney disease on warfarin therapy for atrial fibrillation. JAMA. 2014 Jun 25;311(24):2541–2542.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
June 25, 2014
Volume
311
Issue
24
Start / End Page
2541 / 2542
Location
United States
Related Subject Headings
- Warfarin
- Renal Insufficiency, Chronic
- Myocardial Infarction
- Male
- Humans
- General & Internal Medicine
- Female
- Atrial Fibrillation
- Anticoagulants
- 42 Health sciences